What is leukoaraiosis?

Generally, leukoaraiosis refers to the radiological finding of reduced density in brain white matter, which is a chronic ischemia-induced neurological disorder. If physical discomfort occurs, timely medical consultation is recommended for treatment under the guidance of a qualified physician. Detailed analysis is as follows:

Leukoaraiosis primarily affects the brain's white matter—the part responsible for information transmission within the brain—leading to damage or loss of the myelin sheath surrounding nerve fibers. Clinical manifestations of leukoaraiosis are diverse and may include cognitive decline, memory impairment, slowed reaction time, emotional disturbances, physical disability, and reduced motor function. These symptoms are closely related to the location, severity, and extent of white matter degeneration. Additionally, patients may experience other symptoms such as headache, dizziness, urinary incontinence, and sleep disturbances.

The etiology of leukoaraiosis is complex and may be associated with multiple factors including genetic predisposition, infections, immune responses, unhealthy lifestyle habits, hypertension, and diabetes. Currently, there is no specific treatment for leukoaraiosis; however, disease progression can be slowed through lifestyle modifications and control of blood pressure, blood glucose, and lipid levels. Additionally, physicians may prescribe medications such as enteric-coated aspirin tablets, clopidogrel tablets, and oxiracetam capsules based on the individual patient's condition.

In daily life, patients are advised to maintain a healthy lifestyle and avoid staying up late, which helps enhance immunity and facilitates recovery from the disease.